Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab

We hypothesized whether the reduction in eosinophilic airway inflammation in patients with chronic obstructive pulmonary disease (COPD) following treatment with benralizumab, a humanized, afucosylated, monoclonal antibody that binds to interleukin-5 receptor α, increases the airway bacterial load. A...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Leena, Wright, Adam, Mistry, Vijay, Sutcliffe, Amanda, Chachi, Latifa, Haldar, Koirobi, Ramsheh, Mohammadali Yavari, Richardson, Matthew, van der Merwe, René, Martin, Ubaldo, Newbold, Paul, Brightling, Christopher E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559763/
https://www.ncbi.nlm.nih.gov/pubmed/31239655
http://dx.doi.org/10.2147/COPD.S198302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559763/
https://www.ncbi.nlm.nih.gov/pubmed/31239655
http://dx.doi.org/10.2147/COPD.S198302

Ejemplares similares